Skip to main content
. 2020 Jul 9;10:11344. doi: 10.1038/s41598-020-68226-5

Figure 1.

Figure 1

Optimization and improvement of ex vivo ELISpot assay. (A) Triplicates of 2 × 105 vaccinated donor PBMCs (n = 10) were stimulated at 5 µg/mL/peptide with respective OLP pools. (B) 1–5 × 106 vaccinated donor PBMCs (n = 13) were plated and simultaneously pulsed at 10 µg/mL/peptide with all OLP pools. Signal-to-noise ratios were calculated. (C) 2 × 106 vaccinated donor PBMCs (n = 7) were stimulated with 10, 5, and 1 µg/mL/OLP. (D) 2 × 106 vaccinated donor PBMCs (n = 10) were pulsed at 5 µg/mL/peptide with OLP pools (8) for each HBV antigen. Dotted lines indicate respective positive thresholds.